Consultations

You are here

AVIS DE CONSULTATION N°40-MED-2024 - MORPHINE INJ 2%

by communication / 27 Mar, 2024

AVIS DE PROROGATION - CONSULTATION N°23-MED-2024 - ACICLOVIR INJ 250MG

by communication / 27 Mar, 2024

AVIS D'ATTRIBUTION PROVISOIRE - CONSULTATION N°22-MED-2024 - SALBUTAMOL INJ IV 0.5MG-ML

by communication / 27 Mar, 2024

AVIS DE PROROGATION 2- CONSULTATION N°21-MED-2024 - HUILE DE PARAFFINE LIQ

by communication / 26 Mar, 2024

AVIS DE CONSULTATION N°39-MED-2024 - CHARBON ACTIVE GRANULES POUR SUSPENSION BUVABLE 50G

by communication / 26 Mar, 2024

AVIS DE CONSULTATION N°38-MED-2024 - CHARBON ACTIVÉ SUSPENSION BUVABLE 20G-100ML

by communication / 26 Mar, 2024

AVIS DE CONSULTATION N°37-MED-2024 - AMINOPHYLLINE INJ 250MG

by communication / 26 Mar, 2024

AVIS DE CONSULTATION N°36-MED-2024 - FLUMAZENIL INJ 0,5MG-5ML

by communication / 25 Mar, 2024

AVIS DE PROROGATION 3 CONSULTATION N°12-MED-2024 LEVONOR-ETHINYLESTRAD COMP 0.15-0.03 ET 0.20-0.04 MG

by communication / 24 Mar, 2024

AVIS DE PROROGATION 3 CONSULTATION N°11-MED-2024 AMIODARONE COMP 200MG

by communication / 24 Mar, 2024

Pages

09789332719.png